Associate Director, Technology Evaluation

Planet Pharma; England; On-site; GBP 80,000 - 120,000; Full time

Job summary

A biotechnology company in the UK is seeking an experienced Associate Director, Technology Evaluation to drive strategic evaluation of radiopharmaceutical opportunities in oncology. The ideal candidate will have a PhD in life sciences and experience in R&D, ideally with a focus on molecular imaging and oncology. Join a mission-driven organization that offers competitive compensation and professional growth opportunities.

Benefits

Competitive compensation package

Opportunities for professional growth

Qualifications

• PhD or equivalent experience in relevant fields.
• Strong experience in academic research or R&D within pharma or biotech.
• Deep understanding of oncology biology and diagnostic imaging.
• Track record of managing external collaborations.

Responsibilities

• Understand emerging trends within molecular imaging and oncology.
• Conduct technology and IP landscaping to identify opportunities.
• Lead scientific and technical assessment of new concepts.
• Manage scientific due diligence with internal experts.
• Develop long-term academic collaborations.
• Support R&D teams with competitive intelligence.
• Represent the company externally with key partners.

Skills

Scientific communication

Analytical thinking

Project management

Technology scouting

Collaboration management

Education

PhD in life sciences, molecular imaging, pharmacology, or oncology

Job description

Associate Director, Technology Evaluation – Radiopharmaceutical Innovation

About the Role

We are seeking an experienced and forward‑thinking Associate Director, Technology Evaluation to join a growing, science‑driven client focused on transforming cancer diagnosis and patient management through innovative molecular imaging technologies.

Reporting to the VP, Innovation & Strategy, this role will lead the identification, scientific assessment, and strategic evaluation of new radiopharmaceutical opportunities, with a focus on oncology. You will help shape the company’s R&D strategy by scouting emerging technologies, building academic collaborations, and assessing the potential of novel diagnostic and therapeutic agents.

This is a unique opportunity to combine scientific expertise with strategic influence, driving the next generation of molecular imaging solutions from discovery to development.

Key Responsibilities

• Build a clear understanding of emerging trends within molecular imaging, oncology, and adjacent therapeutic areas
• Conduct technology and IP landscaping to identify promising opportunities
• Lead the scientific and technical assessment of new diagnostic / therapeutic concepts, including suitability, unmet need, competitive positioning, and strategic fit
• Drive and manage scientific due diligence processes with internal subject‑matter experts
• Support internal R&D teams with competitive intelligence and insights for the existing pipeline
• Develop long‑term academic collaborations and evaluate opportunities for grant‑funded research partnerships
• Work closely with cross‑functional colleagues to ensure evidence‑based, confident decision‑making
• Represent the company externally with academic groups, biotech companies, and strategic partners
• Ensure high‑quality communication and documentation throughout all evaluation activities

Qualifications and Experience

• PhD (or equivalent experience) in life sciences, molecular imaging, pharmacology, or oncology‑related field.
• Strong experience in academic research or R&D within pharma or biotech, ideally with exposure to early‑stage development.
• Deep understanding of oncology biology, diagnostic imaging, and emerging therapeutic modalities.
• Experience in technology scouting, evaluation, or competitive intelligence within a scientific context.
• Track record of managing external collaborations or research partnerships.
• Excellent scientific communication, analytical thinking, and project management skills.
• Familiarity with radiopharmaceuticals or nuclear medicine is advantageous but not essential.

Why Join

• Influence the strategic direction of next‑generation radiopharmaceuticals in a fast‑evolving field.
• Collaborate with world‑class scientists, innovators, and global partners.
• Be part of a mission‑led organization advancing diagnostic imaging and improving outcomes for patients with cancer.
• Competitive compensation package and opportunities for professional growth.

Interested?

If you’re passionate about applying scientific insight to strategic innovation in oncology diagnostics, we’d love to hear from you. Apply now to join a growing team that’s redefining the future of molecular imaging.

Tshering Sherpa

[e-mail]